New Kids' flu drug could shorten sick days
NCT ID NCT07357051
First seen Jan 27, 2026 · Last updated May 08, 2026 · Updated 21 times
Summary
This study tests a new flu medicine (JKN2301) in children aged 2 to 11 who have the flu. The goal is to see if it safely reduces symptoms like fever and cough faster than existing treatments. About 177 kids will take part, and researchers will monitor side effects and recovery time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY VIRAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.